Free Trial
OTCMKTS:GSAC

GelStat (GSAC) Stock Price, News & Analysis

GelStat logo
$0.0004
0.00 (0.00%)
(As of 10/31/2024 ET)

About GelStat Stock (OTCMKTS:GSAC)

Key Stats

Today's Range
$0.0004
$0.0004
50-Day Range
N/A
52-Week Range
$0.0002
$0.0006
Volume
N/A
Average Volume
5.91 million shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

GelStat Corporation, a consumer health care company, engages in the research, development, and marketing of over-the-counter and other non-prescription consumer health care products. Its products include GelStat Migraine, a patented solution used for pain relief from migraine headaches; Chews 2 Lose, an appetite suppressant gum for diet aide; All Natural Speed, an energy supplement product; and GelStat Sleep, a product for relief from sleep disorders and its associated symptoms. The company sells its products to retailers, wholesalers, specialty distributors, and catalog merchandisers both directly and through external sales brokers. GelStat Corporation was founded in 2002 and is headquartered in Palm City, Florida.

Receive GSAC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for GelStat and its competitors with MarketBeat's FREE daily newsletter.

GSAC Stock News Headlines

[625,000% Gain] – Are You Ready for the Next Altcoin Boom?
All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you know anything about crypto, you know that altcoin seasons are where some of the biggest gains happen.
See More Headlines

GSAC Stock Analysis - Frequently Asked Questions

GelStat's stock was trading at $0.0003 on January 1st, 2024. Since then, GSAC stock has increased by 33.3% and is now trading at $0.0004.
View the best growth stocks for 2024 here
.

Shares of GSAC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Company Calendar

Today
10/31/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
Pharmaceutical Products
Current Symbol
OTCMKTS:GSAC
Employees
2
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
2.54
20 Stocks to Sell Now Cover

MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.

Get This Free Report

This page (OTCMKTS:GSAC) was last updated on 10/31/2024 by MarketBeat.com Staff
From Our Partners